AN2 Therapeutics Inc
NASDAQ:ANTX
Balance Sheet
Balance Sheet Decomposition
AN2 Therapeutics Inc
AN2 Therapeutics Inc
Balance Sheet
AN2 Therapeutics Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
6
|
4
|
12
|
27
|
16
|
21
|
|
| Cash Equivalents |
6
|
4
|
12
|
27
|
16
|
21
|
|
| Short-Term Investments |
0
|
0
|
47
|
69
|
92
|
62
|
|
| Other Current Assets |
0
|
0
|
2
|
3
|
3
|
3
|
|
| Total Current Assets |
6
|
4
|
60
|
99
|
111
|
86
|
|
| Long-Term Investments |
0
|
0
|
4
|
3
|
27
|
5
|
|
| Other Long-Term Assets |
0
|
0
|
2
|
1
|
1
|
1
|
|
| Total Assets |
6
N/A
|
4
-26%
|
65
+1 455%
|
103
+57%
|
139
+35%
|
92
-34%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
1
|
2
|
3
|
3
|
|
| Accrued Liabilities |
0
|
1
|
2
|
5
|
11
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Current Liabilities |
0
|
2
|
3
|
7
|
14
|
10
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
2
+67%
|
3
+127%
|
7
+112%
|
14
+95%
|
10
-27%
|
|
| Equity | |||||||
| Common Stock |
11
|
23
|
109
|
0
|
0
|
0
|
|
| Retained Earnings |
6
|
20
|
47
|
90
|
154
|
206
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
186
|
279
|
288
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
5
N/A
|
3
-42%
|
62
+2 111%
|
95
+54%
|
125
+31%
|
82
-34%
|
|
| Total Liabilities & Equity |
6
N/A
|
4
-26%
|
65
+1 455%
|
103
+57%
|
139
+35%
|
92
-34%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
19
|
19
|
19
|
19
|
30
|
30
|
|